
EDELWEISS 3 Trial Positive Topline Results: ObsEva S.A. (OBSV) stock Hikes Premarket
On January 06, ObsEva S.A. (OBSV) reported positive topline results from its Phase 3 EDELWEISS 3 Trial in endometriosis-associated pain (EAP). Consequently, the stock was